Growth Metrics

Thermo Fisher Scientific (TMO) Operating Expenses (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Operating Expenses readings, the most recent being $9.1 billion for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 5.71% to $9.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $37.3 billion, a 5.06% increase, with the full-year FY2025 number at $36.8 billion, up 3.57% from a year prior.
  • Operating Expenses hit $9.1 billion in Q1 2026 for Thermo Fisher Scientific, down from $10.0 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $10.0 billion in Q4 2025 to a low of $8.6 billion in Q1 2025.
  • Median Operating Expenses over the past 5 years was $9.0 billion (2025), compared with a mean of $9.1 billion.
  • Biggest five-year swings in Operating Expenses: surged 31.21% in 2022 and later fell 5.81% in 2023.
  • Thermo Fisher Scientific's Operating Expenses stood at $9.6 billion in 2022, then dropped by 5.81% to $9.0 billion in 2023, then rose by 3.84% to $9.4 billion in 2024, then grew by 6.19% to $10.0 billion in 2025, then decreased by 8.21% to $9.1 billion in 2026.
  • The last three reported values for Operating Expenses were $9.1 billion (Q1 2026), $10.0 billion (Q4 2025), and $9.2 billion (Q3 2025) per Business Quant data.